Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:49 PM
Ignite Modification Date:
2025-12-24 @ 11:49 PM
NCT ID:
NCT01973751
Eligibility Criteria:
Group A:
Inclusion Criteria:
* Male and female subjects between the ages of 18 and 70 years
* No respiratory symptoms
* Normal spirometric value and methacholine PD20 \>2.5mg
Group B:
Inclusion Criteria:
* Male and female subjects between the ages of 18 and 70 years
* History of asthma
* No use of oral or inhaled corticosteroids for the treatment of asthma
* No use of leukotriene antagonist for the treatment of asthma
* Hyperreactivity to methacholine (PD20 FEV1 Methacholine \< 2.5 mg) and/or ≥12% increase in FEV1 following inhalation of 200μg salbutamol
* Asthma symptoms of episodic cough, wheeze and/or breathlessness
Exclusion Criteria:
* Current or former smokers
* Pregnant women
* Subjects with a history of lung disease other than asthma
* Subjects with a history of a medical disease, which in the opinion of the investigator may put the subject at extra risk from study-related procedures or because the disease may influence the results of the study
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT01973751
Study Brief:
Protocol Section:
NCT01973751